Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schenkel

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2015
Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockadeKristen E Pauken, Christine E Nelson, Tijana Martinov, et al.
Nature Cancer|November 5, 2021
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancerPeter M K Westcott, Nathan J Sacks, Jason M Schenkel, et al.
Nature|April 21, 2016
Normalizing the environment recapitulates adult human immune traits in laboratory miceLalit K Beura, Sara E Hamilton, Kevin Bi, et al.
Cell Reports|December 5, 2019
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor DevelopmentAmy Li, Rebecca H Herbst, David Canner, et al.
Cancer Research|March 5, 2025
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in MelanomaKelly M Mahuron, Osmaan Shahid, Prachi Sao, et al.
The Lancet. Oncology|February 3, 2022
Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunitiesDiana D Shi, Jimmy A Guo, Hannah I Hoffman, et al.
Science (New York, N.Y.)|October 30, 2016
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockadeKristen E Pauken, Morgan A Sammons, Pamela M Odorizzi, et al.
Nature Medicine|February 28, 2012
NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesAndrew Zloza, Frederick J Kohlhapp, Gretchen E Lyons, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockadeFrederick J Kohlhapp, Joseph R Broucek, Tasha Hughes, et al.
The Journal of Experimental Medicine|July 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashionKristen E Pauken, Samuel C Markson, Thomas S Conway, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2015
Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockadeKristen E Pauken, Christine E Nelson, Tijana Martinov, et al.
Nature Cancer|November 5, 2021
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancerPeter M K Westcott, Nathan J Sacks, Jason M Schenkel, et al.
Nature|April 21, 2016
Normalizing the environment recapitulates adult human immune traits in laboratory miceLalit K Beura, Sara E Hamilton, Kevin Bi, et al.
Cell Reports|December 5, 2019
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor DevelopmentAmy Li, Rebecca H Herbst, David Canner, et al.
Cancer Research|March 5, 2025
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in MelanomaKelly M Mahuron, Osmaan Shahid, Prachi Sao, et al.
The Lancet. Oncology|February 3, 2022
Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunitiesDiana D Shi, Jimmy A Guo, Hannah I Hoffman, et al.
Science (New York, N.Y.)|October 30, 2016
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockadeKristen E Pauken, Morgan A Sammons, Pamela M Odorizzi, et al.
Nature Medicine|February 28, 2012
NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesAndrew Zloza, Frederick J Kohlhapp, Gretchen E Lyons, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockadeFrederick J Kohlhapp, Joseph R Broucek, Tasha Hughes, et al.
The Journal of Experimental Medicine|July 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashionKristen E Pauken, Samuel C Markson, Thomas S Conway, et al.
Pageof 8